Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jan;88(1):64-66.
doi: 10.1007/s12098-020-03428-3. Epub 2020 Jul 9.

Cholestatic Jaundice in Sulphite Oxidase Deficiency - An Unusual Association

Affiliations
Case Reports

Cholestatic Jaundice in Sulphite Oxidase Deficiency - An Unusual Association

Alan Sze Kiat Ong et al. Indian J Pediatr. 2021 Jan.

Abstract

Sulphite oxidase deficiency is an extremely rare inborn error of metabolism of sulphur containing amino acids. There are no reports of liver involvement in this condition. The authors describe a 9-y-old boy with known sulphite oxidase deficiency who presented with worsening cholestatic hepatitis which may be possibly related to underlying metabolic disorder. Although there is no current evidence that treating liver disease and ensuring normal hepatic function in sulphite oxidase deficiency would likely benefit patients, this could potentially contribute to optimising growth and development as well as improving the overall prognosis.

Keywords: Cholestatic hepatitis; Metabolic disorder; Pediatric; Sulphite oxidase deficiency.

PubMed Disclaimer

Comment in

References

    1. Bindu PS, Nagappa M, Bharath RD, Taly AB. Isolated sulfite oxidase deficiency. 2017 Sep 21. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018. Available at: https://www.ncbi.nlm.nih.gov/books/NBK453433/
    1. Johnson JL, Duran M. Molybdenum cofactor deficiency and isolated sulfite oxidase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Vogelstein B, editors. The metabolic and molecular bases of inherited disease, Vol 2. 8th ed. New York: McGraw-Hill; 2001. p. 3163–77.
    1. Cabrera D, Arab JP, Arrese M. UDCA, NorUDCA, and TUDCA in liver diseases: a review of their mechanisms of action and clinical applications. In: Fiorucci S, Distrutti E, editors. Handbook of experimental pharmacology, bile acids and their receptors, vol. 256. Berlin: Springer-Verlag; 2019. p. 237–64.
    1. Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology. 2002;36:525–31. - DOI

Publication types

MeSH terms

Substances

Supplementary concepts

LinkOut - more resources